|Date||Friday, June 25th , 2021|
|Time||8:00 am - 9:30 am|
Expert Session series – The Future of Medicines: Spotlight on Oncology
June 16th AND June 25th
This series will take place over both 16th and 25th June with the sessions building on each other to give attendees a good understanding of Oncology, the challenges continuing to face the industry, and how the patients have been affected.
Week 1 – Wed June 16th, 8am – 9am
We’ll be joined on Wed 16th June by Averil Power, CEO with the Irish Cancer Society along with Eibhlin Mulroe, CEO with Cancer Trials Ireland.
Week 2 – Fri June 25th, 8am – 9.30am
During the second part of the event, we’ll be joined by Prof Seamus O’Reilly, Clinical Medical Oncologist with Cork University Hospital and Vice-Clinical Lead with Cancer Trials Ireland. Joining Prof O’Reilly will be Patricia Heckmann, Chief Pharmacist with the NCCP and Dr Mark Doherty, Consultant Medical Oncologist with St Vincent’s University Hospital.
Introduction to the Speakers:
Prof Seamus O’Reilly, Consultant Medical Oncologist – Cork University Hospital and Vice-Clinical Lead – Cancer Trials Ireland
Prof Seamus O’Reilly is a Consultant Medical Oncologist at Cork University Hospital and Associate Professor at University College Cork. In September 2020 he was appointed Vice-Clinical Lead, Cancer Trials Ireland.
Seamus is a graduate of National University of Ireland (BSc; MB BCh BAO; MD) and Johns Hopkins University (PhD) where he completed training in Medical Oncology. He was the founding trustee and Co-Chairperson Cork ARC Cancer Support House and Co-National Specialty Director Medical Oncology at the Royal College of Physicians.
In 1998 he established a Medical Oncology programme and Cancer Clinical trials unit at Waterford University Hospital and subsequently moved in 2001 to Cork University Hospital establishing a Medical Oncology programme and a Health Research Board funded clinical trials unit there. Seamus is is co-author of over 100 peer reviewed publications and his research interests are in Cancer Therapeutics and Survivorship.
Patricia Heckmann, Chief Pharmacist – National Cancer Control Programme
Patricia Heckmann qualified as a pharmacist at the University of Dublin, Trinity College, before completing a Masters in Health Informatics. She spent 22 years working in hospital pharmacy where she occupied many roles as a Chief Pharmacist before moving to the National Cancer Control Programme in 2013 where she holds the role of Assistant National director Systemic Therapy Programme and Chief Pharmacist. This is a multifaceted national role with a strong focus on patient safety and best practice, which combines project and service development, as well as cross-cutting responsibilities in the areas of tumour guideline development, community oncology and cancer intelligence.
Current key projects include the implementation of the recommendations of the National Cancer Strategy 2017-2026 and the roll out of the National Cancer Information System.
Averil Power, Chief Executive Officer – Irish Cancer Society
Averil is the CEO of the Irish Cancer Society, Ireland’s largest cancer charity. The Irish Cancer Society is a community of patients, survivors, volunteers, supporters, health and social care professionals and researchers, working for a future where no one dies from cancer. The Society directly provides information, services and supports to people affected by cancer; funds life-saving and life-changing research; and drives improvements in public services to advocacy and campaigning.
As CEO, Averil led the development of the Society’s new five-year strategy, launched last year. It sets out an ambitious vision that by 2025, three out of four Irish cancer patients will survive their diagnosis, and everyone affected by the disease will have access to world class treatment, care and support. To achieve this vison and drive forward the strategy, Averil is leading transformational change within the Society and the wider cancer environment.
Averil has almost 20 years’ experience of policy-making, strategic leadership and campaigning as a charity leader, Senator and Government advisor. She has a degree in Business, including not-for-profit management, from Trinity College and is a qualified barrister. Averil is respected in the public space as an advocate and change-maker and was a recipient of a Woman of the Year award for her work on marriage equality.
Eibhlín Mulroe, Chief Executive Officer – Cancer Trials Ireland
Eibhlín is CEO with Cancer Trials Ireland. In June 2015 Eibhlín was appointed CEO of Cancer Trials Ireland (formerly ICORG) and manages a cross functional team including clinical operations, Data & Statistics, Quality and Pharmacovigilance. She has a BSocSc Hons from Queens University Belfast and is an MBA graduate from the Smurfit Business School, University College Dublin. In her early career Eibhlín worked in Irish Politics and then the NGO sector. In July 2007, she became the first CEO of the Irish Platform for Patients’ Organisations, Science and Industry (IPPOSI) and Chair of a Task Force in the European Patient Academy for Therapeutic Innovation (EUPATI). Eibhlín was appointed by the Irish Minister for Health to the Department of Health Steering Group on Rare Disease Policy in 2010, she represented patients on the Health Information and Quality Authority (HIQA) Research Ethics Advisory Board, HIQA, HTA Advisory Board and was a member of the HSE Patient’s Forum. She served as the patient representative on the Legal Consultative Panel of the Irish Medicines Board (now HPRA). Eibhlín led IPPOSI to partake in 2 EC Research Consortiums, BBMRI and EUPATI, the latter is a unique initiative to develop an EU Patient Academy. Eibhlin is a member of the following Boards/Committees. • Governance Committee of Blood Cancer Network Ireland (BCNI). • Steering Group of the Irish Health Research Forum • Advisory Board of the Cork Clinical Research Centre Eibhlin recently stepped down from the HSE’s Ehealth Board which she served on since it’s inception.
Dr Mark Doherty, Consultant Medical Oncologist – St Vincent’s University Hospital
Dr Mark Doherty graduated from University College Dublin in 2006. He completed Basic Specialist Training in Medicine through the Royal College of Physicians of Ireland in 2008 followed Higher Specialist Training in Medical Oncology in 2015. This was followed by a Clinical Fellowship in Medical Oncology at the Princess Margaret Hospital, in Toronto, Ontario, Canada. In 2017 he was awarded a Master’s degree in Clinical Epidemiology and Health Care Research at the University of Toronto. Following this, he was appointed as Assistant Professor at the University of Toronto, and Staff Medical Oncologist at Sunnybrook Odette Cancer Centre from 2017 to 2020. In 2020, he returned to Ireland to an appointment as a Consultant Medical Oncologist at St Vincent’s Hospital Group. His academic focus is on developing therapeutic clinical trials to answer vital clinical questions, and using observational data to better understand treatment responses. He has published academic papers in important medical journals and regularly attends and presents at international oncology meetings.
Gwynne Morley, General Manager – IQVIA Ireland
Also joining the panel will be Gwynne Morley, General Manager with IQVIA Ireland. Gwynne is former Director of Heart & Vascular, Diabetes & Emergency Department at the Mater Private Hospital and former Managing Director at Uniphar Retail Services division. She has extensive experience and knowledge of the pharmaceutical industry, from the manufacturer to the patient. Previously she worked for United Drug Group (UDG) Healthcare for 13 years where she was a member of the Senior Executive team. During her tenure with UDG, she held a number of senior roles namely in pre-wholesale, consumer, homecare and quality. Prior to joining UDG, she held management positions within the Crowley Retail Pharmacy Chain and held a multifunctional role within the medical department of Zeneca Pharma, Ireland. Gwynne is a pharmacy graduate of Trinity College, Dublin.
This Expert Series: The Future of Healthcare – Oncology is proudly sponsored by: